Symbols

Tourmaline Bio (TRML) Plunges 7.37% After Truist Cuts Price Target

Generated by AI AgentAinvest Movers Radar

Thursday, Apr 10, 2025 6:28 pm ET1min read

Tourmaline Bio (TRML) shares fell 3.01% today, reaching their lowest level since October 2023, with an intraday decline of 7.37%.

One of the primary factors influencing the stock price of Tourmaline BioTRML-- (TRML) is the recent adjustment of its price target by Truist. Truist lowered the price target from $74 to $63 while maintaining a Buy rating on the shares. This adjustment could influence investor perception and trading behavior, potentially impacting the stock price.

Ainvest Movers Radar

Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue